Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01373814 · ClinicalTrials.gov registry record
Nutritional Therapy for Diabetic Cardiomyopathy
A clinical trial of T2DM (Type 2 Diabetes Mellitus), sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT01373814: Completed study of T2DM (Type 2 Diabetes Mellitus), sponsored by Washington University School of Medicine.
NCT01373814 is a study of T2DM (Type 2 Diabetes Mellitus) that has completed, run by Washington University School of Medicine. The registered enrollment target is 22 participants, below the 229-participant average among 4 other T2DM (Type 2 Diabetes Mellitus) trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01373814, a study of T2DM (Type 2 Diabetes Mellitus), has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine if nutritional therapy can effectively treat/prevent T2DM and its consequent cardiomyopathy.
Primary Outcome
cardiac function as measured by echocardiography incl. tissue Doppler
Conditions Studied
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2010-09-03 |
| Est. Completion | 2011-06-17 |
What the finished NCT01373814 record still lists
NCT01373814 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 229-participant average among 4 other T2DM (Type 2 Diabetes Mellitus) trials with a reported enrollment target (90% lower).
The record links to 1 condition, with T2DM (Type 2 Diabetes Mellitus) appearing as the primary indexed condition, and to 0 interventions.
NCT01373814 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01373814 about?
NCT01373814 is a clinical study titled "Nutritional Therapy for Diabetic Cardiomyopathy". The goal of this study is to determine if nutritional therapy can effectively treat/prevent T2DM and its consequent cardiomyopathy.
What is the current status of trial NCT01373814?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2010-09-03. Estimated completion is 2011-06-17.
What conditions does trial NCT01373814 study?
This clinical trial studies the following conditions: T2DM (Type 2 Diabetes Mellitus).
Who is sponsoring clinical trial NCT01373814?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01373814 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for T2DM (Type 2 Diabetes Mellitus)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine
RECRUITING · NA
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 2
-
Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D
RECRUITING
-
Virtual Diabetes Group Visits Across Health Systems
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI